BIOMARKER COMPOSITION FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPRISING AIMP1 AND METHOD FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS USING SAME

摘要

The present invention relates to a biomarker composition for diagnosing SLE comprising an AIMP1 as an active ingredient and a method of diagnosing SLE using the same, and particularly the present invention provides a biomarker composition for diagnosing SLE comprising an AIMP1, a kit for diagnosing SLE and a method of diagnosing SLE using the same. Also, the present invention provides a biomarker composition for predicting SLE prognosis comprising AIMP1 as an active ingredient, a kit for predicting SLE prognosis and a method for predicting SLE prognosis using the same. Therefore, AIMP1 of the present invention can be usefully used for diagnosing SLE and predicting SLE prognosis.